Cannabis Clinical Trials Conditions Microdosing 
Cannabis Law Report
JULY 25, 2022
Mindbio Therapeutics , a subsidiary of cannabis and psychedelics holding company Blackhawk Growth Corp. million ($650,000) in funding from New Zealand’s Health Research Council (HRC) to conduct a LSD microdosing trial in patients with Major Depressive Disorder (MDD). Press Release.
The Joint Blog
NOVEMBER 15, 2021
While over the last few years, microdosing has become extremely popular, the act of microdosing has been recommended by experts for at least two decades. There are also many different substances that you can microdose, from psilocybin mushrooms to delta-8. In this article, we are going to cover microdose of legal substances.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 2, 2021
(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.
Cannabis Law Report
JUNE 19, 2022
The market for psychedelic substances is projected to grow rapidly, potentially outpacing the legal US cannabis market. For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art.
The Cannigma
DECEMBER 12, 2022
And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. What is microdosing? How do psychedelics work?
Veriheal
MARCH 20, 2023
Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. appeared first on Cannabis Central.
The Cannigma
JUNE 24, 2021
Hemp and cannabis-derived medications may not be quite as mainstream as apple pie or multivitamins, but the days in which it was an almost completely illegal plant with little if any recognized medical benefits seem like a distant memory. These natural alternatives may also be effective as part of a daily “microdosing” regiment.
Expert insights. Personalized for you.
52 
Let's personalize your content